Nature Reviews Microbiology

Nature Reviews Microbiology is a monthly review journal published by Nature Portfolio that was launched in 2003, covering all aspects of microbiology and related infectious disease research, with a 2025 Journal Impact Factor of 104.6《自然综述：微生物学》（Nature Reviews Microbiology）是 Nature Portfolio 出版的月刊综述期刊，2003 年创刊，覆盖微生物学及感染性疾病研究各领域，2025 年期刊影响因子为 104.6。

Scope

• It embraces microbiology in its broadest sense, taking an integrated approach that bridges fundamental research and its clinical, industrial and environmental applications该刊以最广义的方式涵盖微生物学，采取整合视角，贯通基础研究与其临床、工业与环境应用。
• It publishes high-quality Reviews, Perspectives and Comments on bacteria, archaea, viruses, fungi and protozoa and their interactions with their environments刊载关于细菌、古菌、病毒、真菌与原生动物及其与环境相互作用的权威综述、观点与评论文章。
• The scope includes biochemistry, physiology and molecular biology, genetics and genomics, and ecology, evolution and biodiversity范围包括生物化学、生理学与分子生物学，遗传学与基因组学，以及生态学、演化与生物多样性。
• It also covers cellular microbiology, environmental microbiology, pathogenesis and host defence, and clinical and diagnostic microbiology亦涵盖细胞微生物学、环境微生物学、致病机制与宿主防御，以及临床与诊断微生物学。
• Further topics are infectious diseases, antimicrobial therapies and vaccines, and epidemiology and public health microbiology进一步包括感染性疾病、抗微生物治疗与疫苗，以及流行病学与公共卫生微生物学。
• Applied and industrial microbiology, microbiology education and the relationship between microbiology and society complete the scope应用与工业微生物学、微生物学教育，以及微生物学与社会的关系共同构成其范围。
• It highlights work on biofilms, and its review on the biofilm matrix is among the most cited articles in microbiology该刊重视生物被膜研究，其关于生物被膜基质的综述已成为微生物学领域被引最多的文章之一。^[1]

History

• Nature Reviews Microbiology was launched in 2003 as the first Nature-branded microbiology journal, and its first issue appeared in October 2003该刊于 2003 年创刊，是 Nature 品牌首个微生物学期刊，首期于 2003 年 10 月出版。
• The founding Chief Editor was David O'Connell, and the launch editorial team included Sheilagh Molloy and Susan Jones创刊主编为 David O'Connell，创刊编辑部成员包括 Sheilagh Molloy 与 Susan Jones。
• It has been published by Nature Portfolio, part of Springer Nature, throughout its history该刊自创刊起一直由施普林格·自然旗下的 Nature Portfolio 出版。
• It appears monthly, and the correct abbreviation for abstracting and indexing is Nat. Rev. Microbiol.该刊每月出版，用于文摘与索引的规范缩写为 Nat. Rev. Microbiol.。
• It remains a subscription-based hybrid journal rather than a fully open-access title该刊仍为订阅制混合期刊，并非完全开放获取。
• Its Journal Impact Factor was 69.2 in 2023, 103.3 in 2024 and 104.6 in 2025, ranking first in the Microbiology category其期刊影响因子 2023 年为 69.2，2024 年为 103.3，2025 年为 104.6，在微生物学类别中排名第一。
• An early review from 2004, on bacterial biofilms from the natural environment to infectious diseases, is among the journal's most cited articles2004 年的一篇早期综述，主题为细菌生物被膜从自然环境到感染性疾病，属于该刊被引最多的文章之列。^[2]

Editors

• Like other Nature titles, the journal has no external editorial board, and all editorial decisions are made by a team of full-time professional editors与其他 Nature 系列期刊一样，该刊不设外部编委会，所有编辑决定均由全职专业编辑团队作出。
• The Chief Editor is Ashley York, who studied influenza virus genome replication at the University of Oxford and HIV restriction factors at Rockefeller University, joined the journal in 2016 and became Chief Editor in 2022现任主编为 Ashley York，他曾在牛津大学研究流感病毒基因组复制，并在洛克菲勒大学研究 HIV 限制因子，2016 年加入该刊，2022 年出任主编。
• The Senior Editors are Agustina Taglialegna, who studies bacterial infection and joined from Nature Microbiology in 2022, and Andrea Du Toit, who previously worked at Nature Reviews Molecular Cell Biology高级编辑为 Agustina Taglialegna 与 Andrea Du Toit，前者研究细菌感染并于 2022 年自 Nature Microbiology 转来，后者此前任职于 Nature Reviews Molecular Cell Biology。
• Members of the editorial team are based in London in the United Kingdom and in Berlin in Germany编辑部成员常驻英国伦敦与德国柏林。
• Review and Perspective articles are commissioned, with editors selecting and inviting experts and working with them to develop the scope before peer review综述与观点文章以约稿为主，由编辑遴选并邀请专家，并在同行评审前与作者共同确定文章范围。
• Each manuscript is peer reviewed by typically two to three external experts and undergoes scientific editing, artwork development and copy editing, and the final decision to publish lies with the editors每篇稿件通常由两到三位外部专家评审，并经历科学编辑、图件制作与文字编辑，最终发表决定权归编辑。
• Under Nature Portfolio policy, peer review is single-anonymised by default, with a double-anonymised option available, and reviewers may be named on the published paper依照 Nature Portfolio 政策，同行评审默认单盲，另设双盲选项，审稿人可在发表文章上署名。